20/20 Biolabs, Inc. (AIDX)
Nasdaq: AIDX · Services-Testing Laboratories · Rockville, MD · filing with the SEC since 2002
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 31, 2026 | · |
| Revenue | 2,045,133 | 1,752,343 |
| Cost of revenue | 1,440,592 | 1,392,032 |
| Gross profit | 604,541 | 360,311 |
| Research and development | 592,569 | 1,261,781 |
| Selling, general and administrative | 3,342,843 | 4,759,587 |
| Total operating expenses | 3,935,412 | 6,037,724 |
| Operating income | -3,330,871 | -5,677,413 |
| Interest expense | 156,207 | 12,646 |
| Interest and investment income | 21,399 | 79,467 |
| Other income (expense), net | -115 | 58,925 |
| Total non-operating income (expense) | -407,950 | 125,746 |
| Net income | -3,738,821 | -5,551,667 |
| Earnings per share, basic | -0.76 | -1.16 |
| Earnings per share, diluted | -0.76 | -1.16 |
| Weighted average shares, basic | 4,930,287 | 4,800,524 |
| Weighted average shares, diluted | 4,930,287 | 4,800,524 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding